Showing results (251-260 of 258) with videos related to

Sort By:
Pageof 26
You have reached the last page of results.This site can display upto 258 results.
Frontiers in Oncology|November 24, 2022
Cabozantinib sensitizes microsatellite stable colorectal cancer to immune checkpoint blockade by immune modulation in human immune system mouse modelsJulie Lang, Alexis D Leal, Juan A Marín-Jiménez, et al.
International Journal of Cancer|July 9, 2015
A NOTCH1 gene copy number gain is a prognostic indicator of worse survival and a predictive biomarker to a Notch1 targeting antibody in colorectal cancerJohn J Arcaroli, W M Tai, Ryan McWilliams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2024
A Phase II Study of Potentiation of Pembrolizumab with Binimetinib and Bevacizumab in Refractory Microsatellite-Stable Colorectal CancerRobert W Lentz, Tyler J Friedrich, Patrick J Blatchford, et al.
Cancer Research Communications|October 31, 2025
Phase II Clinical Trial and Preclinical Evaluation of a Novel CD47 Blockade Combination in Refractory Microsatellite-Stable Metastatic Colorectal CancerRobert W Lentz, Julie Lang, Todd M Pitts, et al.
Techniques in Coloproctology|September 14, 2006
Does sodium hyaluronate- and carboxymethylcellulose-based bioresorbable membrane (Seprafilm) decrease operative time for loop ileostomy closure?M Salum, S D Wexner, J J Nogueras, et al.
Nature Medicine|March 1, 2022
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trialAdriaan A Voors, Christiane E Angermann, John R Teerlink, et al.
Frontiers in Immunology|April 15, 2021
Testing Cancer Immunotherapy in a Human Immune System Mouse Model: Correlating Treatment Responses to Human Chimerism, Therapeutic Variables and Immune Cell PhenotypesJuan A Marín-Jiménez, Anna Capasso, Matthew S Lewis, et al.
JAMA Internal Medicine|March 24, 2015
Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trialJean S Kutner, Patrick J Blatchford, Donald H Taylor, et al.
Pageof 26